AI
Babyscripts CEO Anish Sebastian outlines major tech-driven trends to keep an eye on for the new year.
The AI system was able to reduce the percentage of false negative mammograms by 5.7% in the US and 1.2% in the UK.
Scale Venture Partners headed the round, which comes roughly a year and a half after OM1's $21 million Series B.
Accel and 8VC headlined the Mount Sinai-affiliated startup's Series A.
The new tool will also be localized to provide relevant medical information.
The Series C round brings the company's total raise to nearly $52 million.
The Boston-based company has now raised a hair over $90 million for its AI pathology platform.
The investment will be used to build a clinical-stage portfolio for rare diseases, including treatments for Fragile X syndrome.
Q&A: Ieso Digital Health’s SVP of AI on digital therapeutics and the new Eight Billion Minds project
A chat with Valentin Tablan, SVP of AI at British mental health startup Ieso Digital Health.
Also: UCSD researchers employing Nvidia's AI; PatientWisdom's platform launching in Coastal Medical of Rhode Island.